Literature DB >> 9112302

Septic shock in bacteremic patients: risk factors, features and prognosis.

L Leibovici1, M Drucker, H Konigsberger, Z Samra, S Harrari, S Ashkenazi, S D Pitlik.   

Abstract

Of 4,289 episodes of bacteremia detected in 3,631 patients, septic shock was diagnosed in 453 episodes (10.5%). In 56% of shock episodes, septic shock developed more than 24 h after the first positive blood culture was taken. In a logistic regression analysis, variables predictive of septic shock were: advanced age [odds ratio (OR) of 1.015 for an increment of 1 year]; renal failure as an underlying disorder (OR = 1.47); neutropenia (OR of 2.26); curtailed functional capacity (OR of 1.54 for an increment of 1 category); unknown source of infection (OR = 1.66); anaerobic (OR = 2.86), polymicrobial bacteremia (OR = 1.54), or pathogens other than Streptococcus viridans (OR = 0.08 for Streptococcus viridans). The in-hospital mortality associated with septic shock was 80% vs 21% in episodes of bacteremia without shock, and shock episodes accounted for 31% of all deaths. The fatality rate in shock patients given appropriate empiric antibiotic treatment was 74.9% vs 84.7% in patients given inappropriate treatment (p = 0.01). Judging by the present results, host factors are more important determinants for development of septic shock in bacteremic patients than the type of pathogen. Even in patients with shock, appropriate empiric antibiotic treatment was associated with an improved chance of survival.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9112302     DOI: 10.3109/00365549709008668

Source DB:  PubMed          Journal:  Scand J Infect Dis        ISSN: 0036-5548


  20 in total

1.  The importance of a judicious and early empiric choice of antimicrobial for methicillin-resistant Staphylococcus aureus bacteraemia.

Authors:  N Shime; T Kosaka; N Fujita
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-08-14       Impact factor: 3.267

2.  A2B adenosine receptors protect against sepsis-induced mortality by dampening excessive inflammation.

Authors:  Balázs Csóka; Zoltán H Németh; Peter Rosenberger; Holger K Eltzschig; Zoltán Spolarics; Pál Pacher; Zsolt Selmeczy; Balázs Koscsó; Leonóra Himer; E Sylvester Vizi; Michael R Blackburn; Edwin A Deitch; György Haskó
Journal:  J Immunol       Date:  2010-05-26       Impact factor: 5.422

3.  De-escalation of antimicrobials in the treatment of bacteraemia due to antibiotic-sensitive pathogens in immunocompetent patients.

Authors:  N Shime; S Satake; N Fujita
Journal:  Infection       Date:  2011-04-21       Impact factor: 3.553

4.  CD39 improves survival in microbial sepsis by attenuating systemic inflammation.

Authors:  Balázs Csóka; Zoltán H Németh; Gábor Törő; Balázs Koscsó; Endre Kókai; Simon C Robson; Keiichi Enjyoji; Rolando H Rolandelli; Katalin Erdélyi; Pál Pacher; György Haskó
Journal:  FASEB J       Date:  2014-10-15       Impact factor: 5.191

5.  Bundled care for septic shock: an analysis of clinical trials.

Authors:  Amisha V Barochia; Xizhong Cui; David Vitberg; Anthony F Suffredini; Naomi P O'Grady; Steven M Banks; Peter Minneci; Steven J Kern; Robert L Danner; Charles Natanson; Peter Q Eichacker
Journal:  Crit Care Med       Date:  2010-02       Impact factor: 7.598

6.  The influence of infection sites on development and mortality of ARDS.

Authors:  Chau-Chyun Sheu; Michelle N Gong; Rihong Zhai; Ednan K Bajwa; Feng Chen; B Taylor Thompson; David C Christiani
Journal:  Intensive Care Med       Date:  2010-03-13       Impact factor: 17.440

7.  De-escalation of antimicrobial therapy for bacteraemia due to difficult-to-treat Gram-negative bacilli.

Authors:  N Shime; T Kosaka; N Fujita
Journal:  Infection       Date:  2012-12-20       Impact factor: 3.553

Review 8.  [Diagnosis and therapy of sepsis. Guidelines of the German Sepsis Society Inc. and the German Interdisciplinary Society for Intensive and Emergency Medicine].

Authors:  K Reinhart; F Brunkhorst; H Bone; H Gerlach; M Gründling; G Kreymann; P Kujath; G Marggraf; K Mayer; A Meier-Hellmann; C Peckelsen; C Putensen; M Quintel; M Ragaller; R Rossaint; F Stüber; N Weiler; T Welte; K Werdan
Journal:  Internist (Berl)       Date:  2006-04       Impact factor: 0.743

9.  Prevention, diagnosis, therapy and follow-up care of sepsis: 1st revision of S-2k guidelines of the German Sepsis Society (Deutsche Sepsis-Gesellschaft e.V. (DSG)) and the German Interdisciplinary Association of Intensive Care and Emergency Medicine (Deutsche Interdisziplinäre Vereinigung für Intensiv- und Notfallmedizin (DIVI)).

Authors:  K Reinhart; F M Brunkhorst; H-G Bone; J Bardutzky; C-E Dempfle; H Forst; P Gastmeier; H Gerlach; M Gründling; S John; W Kern; G Kreymann; W Krüger; P Kujath; G Marggraf; J Martin; K Mayer; A Meier-Hellmann; M Oppert; C Putensen; M Quintel; M Ragaller; R Rossaint; H Seifert; C Spies; F Stüber; N Weiler; A Weimann; K Werdan; T Welte
Journal:  Ger Med Sci       Date:  2010-06-28

10.  CB2 cannabinoid receptors contribute to bacterial invasion and mortality in polymicrobial sepsis.

Authors:  Balázs Csóka; Zoltán H Németh; Partha Mukhopadhyay; Zoltán Spolarics; Mohanraj Rajesh; Stephanie Federici; Edwin A Deitch; Sándor Bátkai; Pál Pacher; György Haskó
Journal:  PLoS One       Date:  2009-07-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.